These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 23648305)
1. [Neuroendocrine tumors: analysis of 252 cases]. Chi YH; Jiang WC; Du F; Sun YK; Song Y; Yang L; Zhou AP; Wang JW Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):67-70. PubMed ID: 23648305 [TBL] [Abstract][Full Text] [Related]
2. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung. Wolin EM Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas. Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088 [TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system]. Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440 [TBL] [Abstract][Full Text] [Related]
5. The molecular pathogenesis and management of bronchial carcinoids. Cakir M; Grossman A Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849 [TBL] [Abstract][Full Text] [Related]
6. Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma. Kozuki T; Fujimoto N; Ueoka H; Kiura K; Fujiwara K; Shiomi K; Mizobuchi K; Tabata M; Hamazaki S; Tanimoto M J Cancer Res Clin Oncol; 2005 Mar; 131(3):147-51. PubMed ID: 15538626 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms]. Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448 [TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases]. Yao W; Wang W; Li G Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). García-Yuste M; Matilla JM; Alvarez-Gago T; Duque JL; Heras F; Cerezal LJ; Ramos G Ann Thorac Surg; 2000 Jul; 70(1):258-63. PubMed ID: 10921719 [TBL] [Abstract][Full Text] [Related]
10. A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206). Eba J; Kenmotsu H; Tsuboi M; Niho S; Katayama H; Shibata T; Watanabe S; Yamamoto N; Tamura T; Asamura H; ; Jpn J Clin Oncol; 2014 Apr; 44(4):379-82. PubMed ID: 24474818 [TBL] [Abstract][Full Text] [Related]
11. [Treatment strategy for neuroendocrine carcinoma of the lung]. Kawase A; Nagai K Gan To Kagaku Ryoho; 2009 Oct; 36(10):1619-22. PubMed ID: 19838019 [TBL] [Abstract][Full Text] [Related]
12. [Medical treatment of digestive neuroendocrine tumours]. Panzuto F; Nasoni S; Delle Fave G Minerva Endocrinol; 2001 Sep; 26(3):145-8. PubMed ID: 11753237 [TBL] [Abstract][Full Text] [Related]
13. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Tiffet O; Nicholson AG; Ladas G; Sheppard MN; Goldstraw P Chest; 2003 Jul; 124(1):141-6. PubMed ID: 12853516 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study. Hainsworth JD; Spigel DR; Litchy S; Greco FA J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720 [TBL] [Abstract][Full Text] [Related]
15. Use of Molecular Profiling to Guide Treatment Decisions in Patients with Neuroendocrine Tumors: Preliminary Results. Cutler HS; Ogando P; Uhr JH; Gonzalez DO; Warner RR; Divino CM Am Surg; 2016 Apr; 82(4):369-75. PubMed ID: 27097632 [TBL] [Abstract][Full Text] [Related]
17. Carcinoid tumors of the lung. An analysis of 65 operated cases. Stefani A; Morandi U; Urgese AL; Rivasi F; Lodi R J Cardiovasc Surg (Torino); 1999 Aug; 40(4):607-12. PubMed ID: 10532229 [TBL] [Abstract][Full Text] [Related]
18. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†. Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA; Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of neuroendocrine tumors of the digestive tract]. Wada I; Shimizu N; Seto Y Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017 [TBL] [Abstract][Full Text] [Related]
20. Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy. Nio K; Arita S; Isobe T; Kusaba H; Kohashi K; Kajitani T; Tamura S; Hirano G; Mitsugi K; Makiyama A; Esaki T; Ariyama H; Oda Y; Akashi K; Baba E Cancer Chemother Pharmacol; 2015 Apr; 75(4):829-35. PubMed ID: 25702050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]